Acta Medica Saliniana

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

Authors are asked to direct all communication toward Journal Office to the following email address: igor.hudic@ukctuzla.ba

Please avoid sending submissions, manuscripts, forms (except Authorship Statement Form), subscription requests etc. in regular mail. We accept online submissions only.

Editorial board will not disclose any information about manuscripts (including their receipt, content, status in the reviewing process, criticism by reviewers, or ultimate fate) to anyone other than the authors and reviewers.

There is no restriction on the length of the papers. Electronic files regarding the full details of the experimental procedure (conference slides, video sequences, software, etc), which cannot be published in a normal way, can be deposited as supplementary material.

Following guidelines may also be downloaded as PDF file here.

Publication categories

Acta Medica Saliniana publishes original papers, professional papers, review papers, case reports and letters to editor which deal with all aspects of biomedicine and related research.

Criteria for manuscript

Submitted manuscripts must meet the following criteria:

• the material must be original
• the writing must be clear, concise and unambiguous
• the data are valid
• the conclusions drawn by the authors must be reasonable and supportable
• the information must be relevant and interesting.

Corresponding Author (CA)

Corresponding author (CA) is the responsible person for electronically submitting a manuscript for publication consideration. CA must provide complete mailing addresses and e-mail addresses for all the contributing authors. The CA will be identified as such in the published article.

 

Preparing manuscript for submission

Contributors should prepare their manuscripts in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals.

Use Système International (SI) measurements only. Use non-proprietary (i.e. generic) drug names, unless the specific trade name of a drug is directly relevant to the discussion. Avoid unnecessary abbreviations.

Single-space the text throughout. This includes the title page, abstract, text, acknowledgments, references, tables and figure legends. Use Times New Romans/Garamond/Book Antiqua and a 12-point font size.

On the title page DO NOT include the names and affiliations of authors. Authors' full address, phone and fax numbers and e-mail address must be provided during submission process by corresponding author and also as a separate cover page uploaded as a supplementary file. In addition to full title, a short title not more than 60 characters is appreciated.

Include a structured abstract of no more than 250 words with following sections: Background, Aim, Methods, Results, Conclusion. A list of three to five keywords must be given, and placed after the Abstract. PAPERS WITH ABSTRACTS LONGER THAN 250 WORDS WILL BE PROMPTLY RETURNED TO AUTHOR FOR CORRECTION.

For experimental investigations of human or animal subjects, state in the Methods section of the manuscript that an appropriate institutional review board approved the project. Provide the approval numbers as necessary. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained.

Referencing format

Number the references in the order that they appear in the text of the manuscript. When listing references, follow the uniform requirements style (the Vancouver style) that is based largely on an ANSI standard style adapted by the NLM for its databases (e.g., MEDLINE).

Reference numbers should be placed in square brackets [ ] throughout the text, and placed after the punctuation; for example, [4], [2, 3] or [1-3], and all the references should be listed according to the order of their appearance in the manuscript, separately and as the last section at the end of the manuscript.

It is the author's responsibility to check the accuracy of all references by verifying them against the original documents. Citations can be verified by using PubMed's Citation Matcher (http://www.ncbi.nlm.nih.gov/entrez/query/static/citmatch.html).

The format should conform to the examples below:

1. Schindlbeck NE, Ippisch H, Klauser AG et al. Which pH threshold is best in esophageal pH monitoring? Am J Gastroenterol 1991;86:1138-41.

2.Reuter SR, Redman HC. Gastrointestinal Angiography, 2nd edn. WB Saunders: Philadelphia, 1977.

3.McCann JD. Genomic perspectives on probiotics. In: Tanner FX (ed). Probiotics and Prebiotics. Oxford University Press: Oxford, UK, 2001, pp 160-9.

Tables, figures and illustrations

Authors are encouraged to prepare figures and schemes in jpg, tif, png or eps format in 300 dots per inch resolution. Conference slides, video sequences, software, etc., can be included and published as supplementary material.

Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading.

All tables and figures should be numbered in the order of their citation in the text. Include legends for all figures, schemes and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table and after a figure or a scheme.

Original files for figures and shemes in jpg, tif, png or eps format and in 300 dots per inch resolution should be uploaded separately as supplementary files. Graphs should be prefferably prepared with MS Word or MS Excel and original files with data source uploaded as a supplementary file, as well.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

1. By checking this item the submitting author certifies that this manuscript has not been published previously and is not currently under consideration for publication elsewhere.
2. By checking this item the submitting author certifies that all authors made substantive intellectual contributions to the submitted manuscript and that authorship credit is based on the ICMJE criteria for authorship.
3. The submission file is in Microsoft Word, RTF, or WordPerfect document file format. The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
4. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
5. The cover page with authors' names and affiliations is provided as a separate page in supplementary material in order to ensure blind review. Submitting author will provide full names and affiliations during the submission process also.
6. A structured abstract of no more than 250 words has been included with the text. A list of three to five keywords has been given, and placed after the Abstract.
7. Reference numbers have been placed in square brackets [ ] throughout the text, and placed before the punctuation, and numbered in the order that they appear in the text of the manuscript.
8. Listed references (i.e. bibliography at the end) are based on the uniform requirements style (the Vancouver style).

Copyright Notice

Copyright transfer

The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.